“In the UK, more than half of injecting drug users (IDUs) tested positive for the Hepatitis C antibody in 2018.”
ILLY is on a mission to make a real difference to the lives of vulnerable young people and adults who may be at risk of harm caused by the effects of substance misuse. Key within this is taking a personalised treatment approach which is focused on the individual and their family who may also be impacted.
This FocusOn article discusses Hepatitis – what it is, why its important and what we can do to help minimise the risk to communities.
Hep C is a blood-borne virus. In the UK, the main route of transmission for the virus continues to be through injecting drug use and the sharing of unsterilised needles / injecting paraphernalia. Chronic Hep C infections can lead to liver cirrhosis and liver cancer if left untreated.
This article is shared with you to raise the importance of Hepatitis, its screening and how we can continue to work with you to make our communities safer.
Next Steps:
If you have any questions regarding the above, please get in touch with our Client Services team and we’ll be happy to help:
0207 749 2222 
clientservices@illycorp.com